Cargando…
Development of a novel TLR8 agonist for cancer immunotherapy
Toll-like receptors (TLRs) are a family of proteins that recognize pathogen associated molecular patterns (PAMPs). Their primary function is to activate innate immune responses while also involved in facilitating adaptive immune responses. Different TLRs exert distinct functions by activating varied...
Autores principales: | Wang, Yuxun, Yang, Heping, Li, Huanping, Zhao, Shuda, Zeng, Yikun, Zhang, Panpan, Lin, Xiaoqin, Sun, Xiaoxiang, Wang, Longsheng, Fu, Guangliang, Gao, Yaqiao, Wang, Pei, Gao, Daxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607422/ https://www.ncbi.nlm.nih.gov/pubmed/35006413 http://dx.doi.org/10.1186/s43556-020-00007-y |
Ejemplares similares
-
Correction to: Development of a novel TLR8 agonist for cancer immunotherapy
por: Wang, Yuxun, et al.
Publicado: (2021) -
Intratumoral immunotherapy with the TLR7/8 agonist 3M-052
por: Smirnov, DV, et al.
Publicado: (2013) -
Combination of STING and TLR 7/8 Agonists as Vaccine Adjuvants for Cancer Immunotherapy
por: Bhatnagar, Shubhmita, et al.
Publicado: (2022) -
Development of Adamantane-Conjugated TLR7/8 Agonists for Supramolecular Delivery and Cancer Immunotherapy
por: Rodell, Christopher B., et al.
Publicado: (2019) -
Trial Watch: experimental TLR7/TLR8 agonists for oncological indications
por: Frega, Giorgio, et al.
Publicado: (2020)